Management of variceal haemorrhage

Area of Science:

• Hepatology
• Gastroenterology
• Clinical Medicine

Background:

• Variceal bleeding is a critical complication of portal hypertension, carrying high mortality and rebleeding rates.
• Effective management strategies are essential for improving outcomes in cirrhotic patients.

Purpose of the Study:

• To outline optimal management strategies for acute variceal bleeding.
• To detail methods for preventing rebleeding and primary prophylaxis of variceal hemorrhage.

Main Methods:

• Review of current treatment options for acute variceal bleeding, including injection sclerotherapy and drug therapy.
• Discussion of preventative measures such as non-selective beta-blockers and long-term sclerotherapy.
• Consideration of surgical interventions and transjugular intrahepatic portosystemic stent-shunt (TIPSS).

Main Results:

• Injection sclerotherapy is the preferred treatment for acute variceal bleeding.
• Non-selective beta-blockers are the first-line treatment for preventing rebleeding and primary prophylaxis.
• Surgical options and TIPSS are reserved for refractory cases or treatment failures.

Conclusions:

• A sequential, minimally invasive to invasive approach is recommended for managing variceal bleeding.
• Beta-blockers play a key role in both secondary and primary prophylaxis.
• Individualized treatment plans are necessary as the standard approach may not suit all patients.